Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Stewart Website

Donn M. Stewart, M.D.

Selected Publications
1)  Imanguli MM, Karai LJ, Shanti RM, Stewart DM, Brahim JS.
Myofibroblastic tumor of the lower lip in a patient with X-linked hypogammaglobulinemia and isolated growth hormone deficiency: a case report.
J. Oral Maxillofac. Surg. 65: 1219-22, 2007. [Journal]
2)  Stewart DM, Candotti F, Nelson DL.
The Phenomenon of Spontaneous Genetic Reversions in the Wiskott-Aldrich Syndrome: A Report of the Workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006.
J. Clin. Immunol. 27: 634-9, 2007. [Journal]
3)  Stewart DM, Tian L, Notarangelo LD, Nelson DL.
X-linked hypogammaglobulinemia and isolated growth hormone deficiency: an update.
Immunol. Res. 38: 391-9, 2007. [Journal]
4)  Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM, Bryant D, Burt SK, Elnekave E, Hari DM, Wynn TA, Cunningham-Rundles C, Stewart DM, Nelson D, Weinstein JN.
High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID).
BMC Bioinformatics. 6: 168, 2005. [Journal]
5)  Stewart DM, Tian L, Notarangelo LD, Nelson DL.
Update on X-linked hypogammaglobulinemia with isolated growth hormone deficiency.
Current opinion in allergy and clinical immunology. 5: 510-2, 2005. [Journal]
6)  Larocca MC, Shanks RA, Tian L, Nelson DL, Stewart DM, Goldenring JR.
AKAP350 interaction with cdc42 interacting protein 4 at the Golgi apparatus.
Mol. Biol. Cell. 15: 2771-81, 2004. [Journal]
7)  Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, Gandellini F, Stewart DM, Zhu Q, Nelson DL, Notarangelo LD, Ochs HD.
Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.
Blood. 104: 4010-9, 2004. [Journal]
8)  Stewart DM, McAvoy MJ, Hilbert DM, Nelson DL.
B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro.
Clin. Immunol. 109: 137-43, 2003. [Journal]
9)  Qin H, Yamada M, Tian L, Stewart DM, Gulino AV, Nelson DL.
Tracking gene expression in primary immunodeficiencies.
Current opinion in allergy and clinical immunology. 3: 437-42, 2003. [Journal]
10)  Stewart DM, Tian L, Nelson DL.
A case of X-linked agammaglobulinemia diagnosed in adulthood.
Clin. Immunol. 99: 94-9, 2001. [Journal]
11)  Yuan R, Fan S, Achary M, Stewart DM, Goldberg ID, Rosen EM.
Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage.
Cancer Res. 61: 8022-31, 2001. [Journal]
12)  Stewart DM, Tian L, Nelson DL.
Linking cellular activation to cytoskeletal reorganization: Wiskott-Aldrich syndrome as a model.
Current opinion in allergy and clinical immunology. 1: 525-33, 2001. [Journal]
13)  Stewart DM, Lian L, Nelson DL.
The clinical spectrum of Bruton's agammaglobulinemia.
Current allergy and asthma reports. 1: 558-65, 2001. [Journal]
14)  White JD, Wharfe G, Stewart DM, Maher VE, Eicher D, Herring B, Derby M, Jackson-Booth PG, Marshall M, Lucy D, Jain A, Cranston B, Hanchard B, Lee CC, Top LE, Fleisher TA, Nelson DL, Waldmann TA.
The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.
Leuk. Lymphoma. 40: 287-94, 2001. [Journal]
15)  Tian L, Nelson DL, Stewart DM.
Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules.
J. Biol. Chem. 275: 7854-61, 2000. [Journal]

This page was last updated on 12/7/2007.